Related Experiment Video
Updated: Jun 25, 2026

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
[Experimental study of simvastatin induced apoptosis of K562 cells by caspase-12 activation]
Guo-qiang Xu1, Ze-yan Pu, Hua Liu
1Clinical Laboratory Department, Sichuan Academy Medical Sciences and Sichuan Provincial People's Hospital, Chengdu 610072, China.
Objective:
To explore the apoptotic effect of simvastatin on K562 cells through Caspase-12 activation.
Methods:
Morphological changes of apoptotic cells were observed by Hoechst33258 fluorescent staining under fluorescent microscope; Apoptosis rate of cells was determined with annexin V-FITC/PI double staining by flow cytometry; Intracellular calcium concentration ([ca2+]i) was measured by Laser Scanning Confocal Microscope(LSCM); The expression levels of GRP78 and Calpain gene mRNA were determined by RT-PCR; The expression levels of Caspase-3,-6,-7,-9,-12 and GRP78 proteins were evaluated by Western blot.
Results:
Typical morphological changes of K562 apoptosis cells were observed post 72 hours treated with 10, 20, 30 micromol/L simvastatin. The apoptotic rates of K562 cells were (12.41 +/- 0.32)%, (19.08 +/- 0.26)% and (23.41 +/- 0.36)%, respectively. The fluorescent intensities were 43 +/- 2.9, 54 +/- 2.7 and 64 +/- 2.6, respectively in K562 cells treated with 10, 20, 30 micromol/L simvastatin, which represented the increase of [ca2+]i The expression levels of GRP78 and Calpain gene mRNA were up-regulated. And the cleavage and activation of Caspase-3,-6,-7,-9,-12 and upregulation of GRP78 expression were demonstrated by Western blot detection for the treated cells.
Conclusion:
Caspase-12 is a important pathway of apoptosis in cells and participates simvastatin-induced apoptosis in K562 cells.
Insights
Simvastatin induces apoptosis in K562 cells by activating Caspase-12. This study reveals Caspase-12 as a key pathway in simvastatin-mediated apoptosis, highlighting its role in cancer cell death.
Area of Science:
- Cell Biology
- Biochemistry
- Pharmacology
Background:
- K562 cells are a human chronic myeloid leukemia cell line.
- Simvastatin is a statin drug used to lower cholesterol.
- Apoptosis is programmed cell death, crucial in cancer therapy.
Purpose of the Study:
- To investigate the apoptotic effects of simvastatin on K562 cells.
- To determine the role of Caspase-12 activation in simvastatin-induced apoptosis.
Main Methods:
- K562 cells were treated with varying concentrations of simvastatin.
- Apoptosis was assessed using Hoechst staining, flow cytometry (Annexin V-FITC/PI), and caspase activation assays.
- Intracellular calcium levels, and mRNA/protein expression of GRP78, Calpain, and caspases were analyzed.
Main Results:
- Simvastatin induced morphological changes and increased apoptosis rates in K562 cells.
- Intracellular calcium concentration and expression of GRP78 and Calpain mRNA were elevated.
- Cleavage and activation of Caspase-3, -6, -7, -9, and -12 were observed, along with GRP78 protein upregulation.
Conclusions:
- Simvastatin triggers apoptosis in K562 cells.
- Caspase-12 activation is a significant pathway mediating simvastatin-induced apoptosis in these cells.
Related Concept Videos
Caspases
Cellular Injury V: Apoptosis and Autophagy
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway

